Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi(The University of Texas MD Anderson Cancer Center), Sima P. Porten(The University of Texas MD Anderson Cancer Center), Seungchan Kim(Translational Genomics Research Institute), Daniel Willis(The University of Texas MD Anderson Cancer Center), Elizabeth R. Plimack(Fox Chase Cancer Center), Jean Hoffman‐Censits(Thomas Jefferson University Hospital), Beat Roth(The University of Texas MD Anderson Cancer Center), Tiewei Cheng(University of Houston), Mai Tran(University of Houston), I-Ling Lee(The University of Texas MD Anderson Cancer Center), Jonathan Melquist(The University of Texas MD Anderson Cancer Center), Jolanta Bondaruk(The University of Texas MD Anderson Cancer Center), Tadeusz Majewski(The University of Texas MD Anderson Cancer Center), Shizhen Zhang(The University of Texas MD Anderson Cancer Center), Shanna Pretzsch(The University of Texas MD Anderson Cancer Center), Keith Baggerly(The University of Texas MD Anderson Cancer Center), Arlene O. Siefker‐Radtke(The University of Texas MD Anderson Cancer Center), Bogdan Czerniak(The University of Texas MD Anderson Cancer Center), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), David J. McConkey(The University of Texas MD Anderson Cancer Center)
Cited by 1,736
Abstract
Related Papers
Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data
Sandrine Dudoit, Jane Fridlyand, Terence P. Speed|Journal of the American Statistical Association|2002|2.7k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al.|New England Journal of Medicine|2003|2.6k